Compliance Partnerships CIS by Deloitte operates in integrated compliance and commercial services for life sciences and healthcare, presenting a clear cross-sell opportunity to firms seeking to strengthen risk mitigation and governance across multiple business lines.

MSO Advantage Their Managed Services Operations deliver a technology-driven SaaS approach to guide commercial strategies, suggesting opportunities to upsell subscription-based compliance, data analytics, and ongoing operational support for clients pursuing digital transformation.

Risk to Revenue Advisory services focused on identifying risk and building a compliant infrastructure indicate potential for selling end-to-end risk assessment, remediation programs, and scalable controls to larger pharma and health care portfolios.

Mid-market Focus With a midsize employee base and revenue under ten million, CIS by Deloitte can target growing specialty pharma, biotech, and health tech firms seeking enterprise-grade compliance and commercialization solutions without leveraging large-tier consulting firms.

Market Positioning As a Deloitte-backed entity in life sciences compliance, there is a sales angle to leverage credibility and cross-sell with Deloitte’s broader consulting ecosystem for complex regulatory programs, audits, and global market expansion initiatives.